Today’s stock market focus is centered on one single sector: technology stocks. The excitement around artificial intelligence ...

Lee, at this point in the year, all the companies that pay dividends have pretty much set their dividends. You know, the ...

Pfizer PFE is due to report second-quarter results on Aug. 5. All eyes will be on sales of Pfizer’s oncology drugs, which ...

Pfizer witnessed a dramatic 45.77% surge in trading volume, reaching a staggering 11.97 billion shares. Pfizer's stock price ...

The Private Placement included participation by prominent crypto venture capital firms and blockchain infrastructure providers including FalconX, Pantera, Borderless and Relayer Capital with strong ...

Pfizer recently recalibrated its evaluation score, a nod to shifting trends in the market and its own financial pulse. The ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer, Inc.

Bristol Myers and Pfizer will sell Eliquis directly to U.S. patients at a discounted rate with transparent pricing and ...

It might seem counterintuitive to buy safe dividend stocks with “boring” underlying businesses when everyone else is ...

U.S. Bancorp notched a rise in earnings for the latest quarter as it benefited from a lower loan-loss provision and growth in fee income. The healthcare-products maker trimmed and narrowed its ...